Total Payments
$4,942
2024 Payments
$886.77
Companies
26
Transactions
129
Medicare Patients
513
Medicare Billing
$225,613
Payment Breakdown by Category
Food & Beverage$4,786 (96.9%)
Education$155.61 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,786 | 123 | 96.9% |
| Education | $155.61 | 6 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $962.18 | 39 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $474.72 | 15 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $417.78 | 13 | $0 (2022) |
| Mallinckrodt Enterprises LLC | $382.37 | 5 | $0 (2019) |
| Bayer Puerto Rico Inc. | $372.69 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $351.05 | 3 | $0 (2024) |
| Amgen Inc. | $212.57 | 8 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $151.23 | 5 | $0 (2024) |
| Boston Scientific Corporation | $148.78 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $144.94 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $886.77 | 24 | Bayer Puerto Rico Inc. ($257.79) |
| 2023 | $1,165 | 26 | AstraZeneca Pharmaceuticals LP ($193.98) |
| 2022 | $788.54 | 24 | Bayer HealthCare Pharmaceuticals Inc. ($242.31) |
| 2021 | $490.89 | 15 | AstraZeneca Pharmaceuticals LP ($178.71) |
| 2020 | $318.79 | 14 | AstraZeneca Pharmaceuticals LP ($209.77) |
| 2019 | $580.04 | 9 | AstraZeneca Pharmaceuticals LP ($246.41) |
| 2018 | $425.79 | 8 | Mallinckrodt LLC ($246.72) |
| 2017 | $286.27 | 9 | SANOFI-AVENTIS U.S. LLC ($180.00) |
All Payment Transactions
129 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Nephrology | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | Bayer Puerto Rico Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Cardio-renal | ||||||
| 10/02/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Inflammation | ||||||
| 10/01/2024 | Bayer Puerto Rico Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $33.27 | General |
| Category: Cardio-renal | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: DIABETES | ||||||
| 08/27/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $117.88 | General |
| Category: Cardiovascular | ||||||
| 08/23/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $45.10 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | Bayer Puerto Rico Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $34.95 | General |
| Category: Cardio-renal | ||||||
| 08/10/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/16/2024 | Bayer Puerto Rico Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $33.27 | General |
| Category: Cardio-renal | ||||||
| 06/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $77.35 | General |
| Category: Cardio-renal | ||||||
| 06/18/2024 | Bayer Puerto Rico Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $34.95 | General |
| Category: Cardio-renal | ||||||
| 06/11/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Inflammation | ||||||
| 05/21/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Inflammation | ||||||
| 05/08/2024 | Bayer Puerto Rico Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Cardio-renal | ||||||
| 05/02/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: Hyperkalemia | ||||||
| 04/25/2024 | Bayer Puerto Rico Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardio-renal | ||||||
| 04/16/2024 | Bayer Puerto Rico Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardio-renal | ||||||
| 04/11/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/13/2024 | Boston Scientific Corporation | GreenLight XPS (Device) | Food and Beverage | In-kind items and services | $47.11 | General |
| Category: GreenLight_URO | ||||||
| 02/20/2024 | Bayer Puerto Rico Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardio-renal | ||||||
| 02/08/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/28/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 99 | 230 | $26,132 | $18,544 |
| 2022 | 5 | 129 | 343 | $57,079 | $43,278 |
| 2021 | 5 | 156 | 494 | $118,165 | $91,844 |
| 2020 | 4 | 129 | 535 | $92,397 | $71,947 |
Total Patients
513
Total Services
1,602
Medicare Billing
$225,613
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 102 | $13,100 | $8,607 | 65.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 79 | $6,265 | $4,672 | 74.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 32 | $3,817 | $2,992 | 78.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 17 | $2,950 | $2,272 | 77.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 12 | 99 | $29,730 | $23,159 | 77.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 114 | $14,762 | $10,459 | 70.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 85 | $6,065 | $4,675 | 77.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 21 | $4,061 | $3,052 | 75.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 24 | $2,462 | $1,934 | 78.5% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 31 | 243 | $88,265 | $70,244 | 79.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 72 | 144 | $18,950 | $12,982 | 68.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 78 | $5,615 | $4,492 | 80.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 13 | $2,608 | $2,086 | 80.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $2,726 | $2,040 | 74.8% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 22 | 213 | $62,164 | $49,180 | 79.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 40 | 196 | $14,455 | $11,468 | 79.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 52 | 107 | $11,856 | $8,174 | 68.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 15 | 19 | $3,922 | $3,124 | 79.7% |
About Dr. Avid Muniz, M.D
Dr. Avid Muniz, M.D is a Nephrology healthcare provider based in Santurce, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417919804.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Avid Muniz, M.D has received a total of $4,942 in payments from pharmaceutical and medical device companies, with $886.77 received in 2024. These payments were reported across 129 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,786).
As a Medicare-enrolled provider, Muniz has provided services to 513 Medicare beneficiaries, totaling 1,602 services with total Medicare billing of $225,613. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Santurce, PR
- Active Since 04/03/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417919804
Products in Payments
- LOKELMA (Drug) $904.33
- Kerendia (Drug) $847.41
- ACTHAR (Biological) $523.55
- ELIQUIS (Drug) $371.05
- JARDIANCE (Drug) $151.23
- Parsabiv (Biological) $140.21
- SOLIQUA (Drug) $140.00
- JYNARQUE (Drug) $125.00
- Veltassa (Drug) $124.95
- MICRA (Device) $114.70
- WATCHMAN (Device) $101.67
- SOLIQUA 100/33 (Biological) $100.00
- TOUJEO (Drug) $100.00
- XARELTO (Drug) $99.98
- ZERBAXA (Drug) $87.59
- TARPEYO (Drug) $82.44
- Xience V coronary stent system (Device) $58.94
- RENVELA (Drug) $57.78
- TAVNEOS (Drug) $54.03
- FARXIGA (Drug) $51.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.